5.0
14. Jan. 2021
Aktueller Mitarbeiter, weniger als 1 Jahr
London, England
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
- Good AI device developed by good science and clinical rigour - Motivated and supporting team with a "can-do" approach - Lots of potential to expand over the next year
Kontras
- As any startup in its growth period, lots to do! which is not necessarily a bad thing